NVAX
Novavax
$9.30
−$0.55 (−5.58%)Sep 10, 2026
Key metrics
The numbers that frame NVAX today
- Market cap
- $1.53B
- P/E (TTM)
- -6.2
- EV / FCF
- -38.1
- Gross margin
- 78.6%
- EV / Sales
- 4.0
- ROIC
- -36%
- Div yield
- 0%
- 52wk Low
- $6.20
- 52wk High
- $11.97
Growth
Revenue and earnings trend for NVAX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NVAX
Is Novavax a good buy?
Hold. Novavax has excellent quality, but weak momentum makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Novavax is selling at a high price.
What is the market capitalization of NVAX?
Novavax's market capitalization is $1.53B.
What is the P/E ratio for NVAX stock?
Novavax's current P/E ratio is -6.2.
What is the 52-week high for NVAX stock?
The 52-week high for Novavax is $11.97. The current close of $9.30 is 22.3% below that high.
What is the 52-week low for NVAX stock?
The 52-week low for Novavax is $6.20. The current close of $9.30 is 50% above that low.
Does NVAX stock pay dividends?
Novavax does not currently show a dividend per share in the company data.